The occasion recognises a decade of compassionate, connected cancer care and the role Singapore has played in advancing cancer services across Singapore, ASEAN and the broader Icon Group network.
Since partnering with Singapore Oncology Consultants in 2016, Icon Cancer Centre Singapore has grown from four centres and a team of seven medical oncologists into an integrated cancer care network supported by more than 100 specialists.
Throughout that growth, its focus has remained on supporting and improving the experience of patients through every stage of their cancer journey.
More importantly, the growth of the organisation has always been measured by the difference it makes to the lives of patients and their families.
As CEO of Icon ASEAN Serena Wee, reflects, the organisation’s success has been driven by a simple commitment to keeping patients at the centre of every decision.
From expanding services and strengthening clinical capability to forging partnerships throughout the region, every step has been guided by a commitment to improving access to high-quality cancer care.
Over the past ten years, patients have benefited from expanded treatment locations, the introduction of radiation oncology, haematology and health screening services, the launch of clinical trials and continued investment in innovative care models.
The organisation has also earned recognition for quality and excellence, including the AustCham Business Excellence Award in 2019 and 2024 and being the first oncology provider in ASEAN to receive the Australian Council on Healthcare Standards International (ACHSI) accreditation.
Central to this success has been Icon’s integrated approach to care. The result is a more connected experience that reduces complexity and ensures patients can access expert care closer to home.
For Medical Director Dr Karmen Wong, the anniversary is a celebration of progress and recognition of the people who have shaped the journey.
“Over the past decade we have witnessed remarkable advances in treatment, technology and patient support,” she said.
“Yet at the heart of everything remains the relationship between patients and the teams who care for them.”
Singapore’s success has also become the foundation for broader regional growth.
Through expansion across Malaysia and Indonesia, Icon is extending its model of care to more communities, while combining local expertise with the strength of a global network.
Today, Singapore remains a critical hub for clinical leadership, innovation and partnership across Icon’s ASEAN operations.
According to Icon Group CEO Mark Middleton, the achievements of the Singapore team reflect the organisation’s values and long-term vision.
“The story of Singapore is one of partnership and purpose,” he said.
“It demonstrates what can be achieved when we combine world-class clinical expertise with a relentless focus on improving outcomes and experiences for patients.”
With growing investment in clinical trials, precision medicine, theranostics and regional collaboration, Icon Cancer Centre Singapore is already helping shape the next generation of cancer care. These advances will support greater access to innovative treatments while ensuring care remains personal, connected and centred on patient outcomes.
As the organisation celebrates ten years in Singapore, the milestone is a point of reflection and a signal of intent.
The patients, clinicians, partners and communities who have shaped the first decade are at the centre of the next and driving forward the shared ambition to deliver the best care possible, to as many people as possible, closer to home.
Icon Group is Australia’s largest dedicated cancer care provider and has expanded globally into New Zealand, Asia and the United Kingdom.
People from across Icon Group share their stories of success, career progression and being iconic.
At Icon, you’ll help change lives, every single day. In return for your passion, dedication and agility, we offer a workplace where you can.
Read the latest news and updates across Icon Group.